Since 1994, the author has used methocarbamol as an adjunct for pain management in patients undergoing subpectoral breast implant surgery. According to his observations, methocarbamol results in a decrease in postoperative pain and use of intravenous narcotics, as well as significant improvement in postoperative functioning. (Aesthetic Surg J 2002;22:380-381.).

Methocarbamol effectively reduces postoperative pain and narcotic use in breast implant surgery, improving postoperative functioning and quality of life.

Paper

Methocarbamol: adjunct therapy for pain management in breast augmentation.

References

Citations